| - GRCh37:
- Chr16:75663351
- GRCh38:
- Chr16:75629453
| KARS1 | P349A, P505A, P533A | Autosomal recessive nonsyndromic hearing loss 89 | Uncertain significance (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:75664388
- GRCh38:
- Chr16:75630490
| KARS1, LOC126862402 | E297Q, E453Q, E481Q | Autosomal recessive nonsyndromic hearing loss 89 | Uncertain significance (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:75661893
- GRCh38:
- Chr16:75627995
| KARS1 | | Autosomal recessive nonsyndromic hearing loss 89 | Pathogenic (Feb 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:75668189
- GRCh38:
- Chr16:75634291
| KARS1 | I110T, I266T, I294T | not provided, Autosomal recessive nonsyndromic hearing loss 89 | Uncertain significance (Dec 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:75674253-75674255
- GRCh38:
- Chr16:75640355-75640357
| KARS1 | | Charcot-Marie-Tooth disease recessive intermediate B, Leukoencephalopathy, progressive, infantile-onset, with or without deafness, Deafness, congenital, and adult-onset progressive leukoencephalopathy, Autosomal recessive nonsyndromic hearing loss 89, not provided | Benign/Likely benign (May 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:75663371
- GRCh38:
- Chr16:75629473
| KARS1, LOC126862402 | A526V, A498V, A342V | Global developmental delay, Leukodystrophy, Autosomal recessive nonsyndromic hearing loss 89, Autosomal recessive nonsyndromic hearing loss 89, Global developmental delay, Leukodystrophy, Sensorineural hearing loss disorder | Conflicting interpretations of pathogenicity (Jan 30, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:75669586
- GRCh38:
- Chr16:75635688
| KARS1 | F291V, F263V, F107V | not provided, Autosomal recessive nonsyndromic hearing loss 89 | Conflicting interpretations of pathogenicity (Mar 30, 2021) | criteria provided, conflicting interpretations |
| | | | Leukoencephalopathy, Deafness | Pathogenic (Jun 1, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr16:75663434
- GRCh38:
- Chr16:75629536
| KARS1, LOC126862402 | R477H, R505H, R321H | Autosomal recessive nonsyndromic hearing loss 89 | Pathogenic (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:75662462
- GRCh38:
- Chr16:75628564
| KARS1 | | Autosomal recessive nonsyndromic hearing loss 89 | Likely benign (Jan 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:75674196
- GRCh38:
- Chr16:75640298
| KARS1 | E120Q, E92Q | Autosomal recessive nonsyndromic hearing loss 89, Leukoencephalopathy, progressive, infantile-onset, with or without deafness, Deafness, congenital, and adult-onset progressive leukoencephalopathy, Charcot-Marie-Tooth disease recessive intermediate B, not specified, not provided
| Uncertain significance (Dec 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:75661803
- GRCh38:
- Chr16:75627905
| KARS1 | T623S, T595S, T439S | Autosomal recessive nonsyndromic hearing loss 89, not specified, not provided
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:75669880
- GRCh38:
- Chr16:75635982
| KARS1 | P200L, P228L, P44L | KARS1-related disorder, Charcot-Marie-Tooth disease recessive intermediate B, Leukoencephalopathy, progressive, infantile-onset, with or without deafness, KARS-related disorders, not provided, Autosomal recessive nonsyndromic hearing loss 89, Inborn genetic diseases | Pathogenic/Likely pathogenic (Nov 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:75665624
- GRCh38:
- Chr16:75631726
| KARS1 | D377N, D349N, D193N | not provided | Uncertain significance (Jun 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:75670401
- GRCh38:
- Chr16:75636503
| KARS1 | Y173H, Y145H | Leukoencephalopathy, progressive, infantile-onset, with or without deafness, Nonsyndromic genetic hearing loss | Conflicting interpretations of pathogenicity (Jan 3, 2022) | criteria provided, conflicting interpretations |